Accelerant Holdings (ARX)
| Market Cap | 4.31B -4.5% |
| Revenue (ttm) | 1.07B +55.3% |
| Net Income | -1.37B |
| EPS | -6.29 |
| Shares Out | 217.19M |
| PE Ratio | n/a |
| Forward PE | 23.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,248,297 |
| Open | 19.80 |
| Previous Close | 19.88 |
| Day's Range | 19.73 - 19.90 |
| 52-Week Range | 9.18 - 20.51 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 23.50 (+18.45%) |
| Earnings Date | Aug 13, 2026 |
About ARX
Accelerant Holdings, together with its subsidiaries, operates a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. It operates through Exchange Services, MGA Operations, and Underwriting segments. The Exchange Services segment consists of risk exchange, its operating platform that incorporates various technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its Risk capital partners write premiums directly through the Risk Exchange... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for ARX stock is "Hold." The 12-month stock price target is $23.5, which is an increase of 18.45% from the latest price.
News
Accelerant downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst C. Gregory Peters downgraded Accelerant (ARX) to Market Perform from Outperform without a price target after the company agreed to be taken private by Thoma Bravo for…
Accelerant to be acquired by Thoma Bravo in all-cash deal worth more than $4B
06:33 EDT Accelerant (ARX) to be acquired by Thoma Bravo in all-cash deal worth more than $4B
Accelerant to be acquired by Thoma Bravo for $20.25 per share in cash
Accelerant (ARX) announced that it has entered into a definitive agreement with Thoma Bravo to become a privately held company in an all-cash transaction with an enterprise value of more…
Accelerant reports Q2 adjusted EPS 32c, consensus 16c
Reports revenue $356.9M, consensus $278.78M. “Accelerant (ARX) has been building the preeminent specialty insurance marketplace since our founding in 2018,” said Jeff Radke, Chairman and CEO. “I am pr...
Accelerant downgraded to Market Perform from Outperform at William Blair
William Blair analyst Adam Klauber downgraded Accelerant (ARX) to Market Perform from Outperform after the company entered into an agreement to be taken private by Thoma Bravo for $20.25 per…
Accelerant downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler analyst Paul Newsome downgraded Accelerant (ARX) to Neutral from Overweight with a price target of $20.25, up from $19, after the company agreed to be taken private by…
Accelerant downgraded to Market Perform from Outperform at Citizens
Citizens downgraded Accelerant (ARX) to Market Perform from Outperform without a price target after the company agreed to be taken private by Thoma Bravo for $20.25 per share in cash.
Accelerant downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Accelerant (ARX) to Sector Perform from Outperform with a price target of $20.25, up from $18, after the company agreed to be taken private by Thoma Bravo…
Accelerant Holdings Proxy statement: Proxy filing
Accelerant Holdings filed a proxy statement on August 14, 2026, providing details for shareholder voting and corporate governance matters.
Accelerant Holdings Proxy statement: Proxy filing
Accelerant Holdings filed a proxy statement on August 14, 2026, providing details for shareholder voting and corporate governance matters.
Accelerant (ARX) Stock Rockets 44% on a $4B Acquisition Deal with Thoma Bravo
Accelerant stock was up on Thursday after the company announced a $4 billion acquisition deal with Thoma Bravo.
Accelerant Holdings Earnings release: Q2 2026
Accelerant Holdings released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Accelerant Holdings Quarterly report: Q2 2026
Accelerant Holdings has published its Q2 2026 quarterly earnings report on August 13, 2026.
Accelerant Holdings Proxy statement: Proxy filing
Accelerant Holdings filed a proxy statement on August 13, 2026, providing details for shareholder voting and corporate governance matters.
Accelerant Holdings Proxy statement: Proxy filing
Accelerant Holdings filed a proxy statement on August 13, 2026, providing details for shareholder voting and corporate governance matters.
Accelerant Announces Second Quarter 2026 Results
ATLANTA--(BUSINESS WIRE)--Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced...
Accelerant to Go Private in $4.4B Deal with Thoma Bravo
The data-driven risk exchange agreed to go private in a deal with private-equity firm Thoma Bravo worth more than $4 billion.
Thoma Bravo to take Accelerant private in more than $4 billion deal
Accelerant said on Thursday that private equity firm Thoma Bravo will take the insurance marketplace private in an all-cash deal worth more than $4 billion.
Accelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo
ATLANTA--(BUSINESS WIRE)--Accelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo.
Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call
ATLANTA--(BUSINESS WIRE)--Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call.
Accelerant announces partnership with third-party capitalized insurer WoodStar
Accelerant (ARX) announced a partnership with newly formed WoodStar Reciprocal Exchange. WoodStar is a reciprocal insurance company funded with more than $220M of surplus notes and capital from unrela...
Accelerant Announces Partnership With New Third-Party Capitalized Insurer WoodStar
ATLANTA--(BUSINESS WIRE)--Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced a partne...
Accelerant price target lowered to $14 from $16 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Accelerant (ARX) to $14 from $16 and keeps an Equal Weight rating on the shares. Heading into earnings, property and casualty insurance…